Background
==========

Asthma is a chronic inflammatory airway disorder characterized by airway hyper-responsiveness, reversible airway obstruction, and airway remodeling \[[@b1-medscimonit-21-3591],[@b2-medscimonit-21-3591]\]. It is commonly thought that asthma is a multi-factorial disease resulting from complex interactions between genetic predisposition and environmental factors \[[@b3-medscimonit-21-3591]\]. Studies have shown that genetic influences on asthma are substantial, with heritability estimates ranging between 35% and 95% \[[@b4-medscimonit-21-3591]\]. Notably, a large number of polymorphisms in genes positioned throughout the genome have been implicated in asthma causation, including the gene encoding Toll-like receptor 4 (TLR4) \[[@b5-medscimonit-21-3591]\].

Toll-like receptors (TLRs) are a class of evolutionarily conserved membrane-bound pattern recognition receptors (PRRs) presented on the cell surface of innate immune cells. TLRs recognize pathogen-associated molecular patterns (PAMPs) exclusively expressed by microbial pathogens, and activate cellular signaling pathways to induce immune-response genes, including inflammatory cytokines \[[@b6-medscimonit-21-3591]\]. Ten different human TLRs have been identified. TLR4, the best-studied TLR, is expressed on macrophages, dendritic cells, and other cell types, and mainly recognizes lipopolysaccharide (LPS) of gram-negative bacteria \[[@b7-medscimonit-21-3591],[@b8-medscimonit-21-3591]\]. Interaction of LPS with TLR4 can activate the nuclear factor kappa B (NF-κB) signaling pathway, increase expression of inflammatory cytokines and disturb the Th1/Th2 balance in asthma \[[@b9-medscimonit-21-3591]\]. TLR4 also regulates innate immune responses to respiratory syncytial virus infection, which is a risk factor for the development of asthma \[[@b10-medscimonit-21-3591]\].

Human TLR4 gene is located on chromosome 9q32-q33 \[[@b11-medscimonit-21-3591]\]. Two single-nucleotide polymorphisms (SNPs), TLR4 +896A/G (rs4986790, also known as Asp299Gly) and TLR4 +1196C/T (rs4986791, also known as Thr399Ile), have been demonstrated to modify the receptor's response to endotoxin, which is an important trigger of asthma \[[@b12-medscimonit-21-3591]\]. This genetically determined alteration in endotoxin responsiveness may be involved in the development of asthma. Several studies have evaluated the association of TLR4 +896A/G and +1196C/T polymorphisms with asthma \[[@b13-medscimonit-21-3591]--[@b31-medscimonit-21-3591]\]. However, due to the limitation of subjects, the results were inconsistent and controversial. A previous meta-analysis has shown a marginal association of TLR4 +896A/G with asthma, and no association between TLR4 +1196C/T polymorphism and asthma \[[@b32-medscimonit-21-3591]\], but it did not cover all eligible studies. The exact correlation between TLR4 +896A/G and +1196C/T polymorphisms and asthma has not been entirely established. Therefore, we performed a meta-analysis including all eligible case-control studies to clarify and quantify the authentic effect of TLR4 +896A/G and +1196C/T polymorphisms on the risk of asthma.

Material and Methods
====================

This study was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.

Literature search strategy
--------------------------

A literature search was performed using PubMed, Embase, Web of Science, Chinese National Knowledge Infrastructure (CNKI), and Wanfang Data from inception to July 2015. The search strings was: ("asthma" or "asthmatic") and ("toll-like receptor 4" or "TLR4") and ("mutation" or "polymorphism" or "variant"). The reference lists of the identified articles were also examined. No restrictions were applied for language, population, sample size, publication date, or type of report.

Inclusion and exclusion criteria
--------------------------------

Studies were included in the meta-analysis that met the following criteria: 1) case-control study design, 2) evaluation of the association between the TLR4 +896A/G (Asp299Gly) and +1196C/T (Thr399Ile) polymorphisms and risk of asthma, 3) genotype frequency was available or sufficient data could be extracted to calculate odds ratios (ORs) and 95% confidence intervals (CIs), and 4) not animal studies. For overlapping studies, the most recent article or the one with the largest sample size was selected. Studies were excluded if they did not meet these inclusion criteria. Unpublished data were not considered.

Data extraction
---------------

The following data were extracted: year of publication, first author, country, ethnicity, age, atopic status, detection methods, sample size, and genotype frequencies in cases and controls. Two investigators independently extracted data. Disagreements were resolved by discussion and consensus.

Statistical analysis
--------------------

All the statistical analyses were conducted using STATA software version 12.0 (STATA Corporation, College Station, TX, USA). We first evaluated Hardy-Weinberg equilibrium (HWE) in the control group for each study using the chi-square test, and it was considered statistically significant when P\<0.05. A statistical test was performed based on the Q statistic to assess heterogeneity. The P\>0.10 of the Q test indicated a lack of heterogeneity among studies. If heterogeneity was observed among studies, the random-effects model was used. Otherwise, the fixed-effects model was adopted. The strength of association between TLR4 +896A/G and +1196C/T polymorphisms and the risk of asthma was assessed by calculating ORs with 95% CIs. Stratified analysis was performed by ethnicity, if possible. Potential publication bias was assessed by Begg's rank correlation test and Egger's linear regression test, and P\<0.05 was considered significant publication bias.

Results
=======

Study characteristics
---------------------

The study selection process was shown in [Figure 1](#f1-medscimonit-21-3591){ref-type="fig"}. In total, 72 English articles and 119 Chinese articles met search criteria after we initially searched PubMed, Embase, Web of Science, CNKI, and Wanfang Data. After reading titles and abstracts, 131 articles were excluded because they did not refer to TLR4 gene polymorphisms and asthma risk. The remaining 60 articles were identified for full-text view; 22 were excluded because they investigated other gene polymorphisms, 16 were excluded because they were reviews, 2 were not case-control studies, and 1 was repeated. A total of 19 relevant studies investigating the TLR4 +896A/G and +1196C/T polymorphisms and asthma for meta-analysis were identified. However, 5 studies were monomorphic at site and were excluded from this meta-analysis \[[@b15-medscimonit-21-3591],[@b21-medscimonit-21-3591],[@b22-medscimonit-21-3591],[@b29-medscimonit-21-3591],[@b30-medscimonit-21-3591]\]. Finally, 14 case-control studies were included in the present meta-analysis. The characteristics of the selected studies are listed in [Table 1](#t1-medscimonit-21-3591){ref-type="table"}, with a total of 13 studies of 2649 asthma cases and 2542 controls for investigating +896A/G polymorphism and 7 studies of 1443 asthma cases and 1693 controls for +1196C/T polymorphism. As for ethnicity, 11 studies investigated white populations \[[@b13-medscimonit-21-3591],[@b17-medscimonit-21-3591],[@b19-medscimonit-21-3591],[@b20-medscimonit-21-3591],[@b23-medscimonit-21-3591]--[@b28-medscimonit-21-3591],[@b31-medscimonit-21-3591]\], 2 studies investigated Asian populations \[[@b16-medscimonit-21-3591],[@b18-medscimonit-21-3591]\], and 1 study investigated the U.S. population \[[@b14-medscimonit-21-3591]\]. Deviation from HWE was detected in the controls of 2 eligible studies \[[@b13-medscimonit-21-3591],[@b16-medscimonit-21-3591]\]. The genotype frequencies of TLR4 +896A/G and +1196C/T polymorphisms in each study are presented in [Table 2](#t2-medscimonit-21-3591){ref-type="table"}.

Main results of the meta-analysis
---------------------------------

The main results of the relationship between TLR4 +896A/G and +1196C/T polymorphisms and asthma risk are listed in [Table 3](#t3-medscimonit-21-3591){ref-type="table"}. Overall, no significant association between TLR4 +896A/G polymorphism and asthma risk was found in the allele model (G *vs.* A: OR=1.05, 95% CI=0.90--1.23, P=0.51), the dominant model (GG + AG *vs.* AA: OR=1.05, 95% CI=0.89--1.24, P=0.56), or the codominant models (AG *vs.* AA: OR=1.04, 95% CI=0.88--1.23, P=0.64). After categorizing subjects into different subgroups on the basis of ethnicity, the results remained non-significant ([Figure 2](#f2-medscimonit-21-3591){ref-type="fig"}). The recessive model (GG *vs.* AG+AA) and codominant model (GG *vs.* AA) were not performed due to the low frequency of the GG genotype in cases and controls.

As for TLR4 +1196C/T polymorphism, a protective association was found between TLR4 +1196C/T polymorphism and asthma in the allele model (T *vs.* C: OR=0.79, 95%CI=0.63--0.99, P=0.04), the dominant model (TT+CT *vs.* CC: OR=0.76, 95%CI=0.59--0.96, P=0.03), and the codominant model (CT *vs.* CC: OR=0.74, 95%CI=0.58--0.95, P=0.02). This association was not examined via the recessive model (TT *vs.* CT+CC) or codominant model (TT *vs.* CC) due to the low frequency of the TT genotype in cases and controls. The subgroup analysis by ethnicity showed that the T allele of TLR4 +1196C/T polymorphism was a significant protective gene for the development of asthma in Asians (T *vs.* C: OR=0.73, 95%CI=0.54--0.98, P=0.04; TT+CT *vs.* CC: OR=0.70, 95%CI=0.51--0.96, P=0.03; CT *vs.* CC: OR=0.69, 95%CI=0.50--0.96, P=0.03), but there was no statistically significant difference in whites (T *vs.* C: OR=0.87, 95%CI=0.60--1.26, P=0.46; TT+CT *vs.* CC: OR=0.84, 95%CI=0.57--1.24, P=0.39; CT *vs.* CC: OR=0.82, 95%CI=0.55--1.22, P=0.33) ([Figures 3](#f3-medscimonit-21-3591){ref-type="fig"}[](#f4-medscimonit-21-3591){ref-type="fig"}--[5](#f5-medscimonit-21-3591){ref-type="fig"}).

Test of heterogeneity, sensitivity analysis, and publication bias
-----------------------------------------------------------------

There was no significant heterogeneity between any studies when analyzing the association of TLR4 +896A/G and +1196C/T polymorphisms and asthma risk in all genetic models, so we used fixed-effects models. Sensitivity analyses were conducted by altering the statistical models. No material alterations were detected, indicating that our results were statistically robust. Exclusion of the HWE-deviated studies did not meaningfully change the pooled estimates (data not shown). The funnel plot was used to evaluate publication bias, and there was no obvious asymmetry. Furthermore, no significant publication bias was detected by Begg's test and Egger's test (all P\>0.05).

Discussion
==========

Asthma is a chronic inflammatory airway disorder with complex etiologies involving both genetic and environmental contributions. Several candidate genes, such as TLR4, CD14, STAT6, ADAM33, and IL-13, have been reported to be associated with asthma susceptibility \[[@b18-medscimonit-21-3591],[@b33-medscimonit-21-3591]--[@b36-medscimonit-21-3591]\]. TLR4 is a principal receptor for LPS. Recognition of LPS by TLR4 plays a crucial role in the activation of subsequent immune and inflammatory responses against invaders. Numerous studies have indicated the role of TLR4 in the pathogenesis of asthma \[[@b37-medscimonit-21-3591]--[@b40-medscimonit-21-3591]\]. TLR4 is up-regulated in patients with asthma/allergic rhinitis \[[@b37-medscimonit-21-3591]\]. Bortolatto et al. demonstrated that LPS impair the development of Th2 immunity, signaling via TLR4 and MyD88 molecules and via the IL-12/IFN-γ axis, and the synthetic TLR4 agonists protect against allergic asthma development \[[@b41-medscimonit-21-3591]\]. Genetic polymorphisms of TLR4 gene have been demonstrated to be associated with diminished airway responsiveness to inhaled LPS \[[@b42-medscimonit-21-3591]\], and to be closely involved in the susceptibility to many diseases, including asthma, juvenile spondyloarthritis, inflammatory bowel disease, and systemic lupus erythematosus \[[@b18-medscimonit-21-3591],[@b43-medscimonit-21-3591]--[@b45-medscimonit-21-3591]\].

Two co-segregating single-nucleotide polymorphisms, +896 A/G and +1196C/T, in human TLR4 gene that result in amino acid changes in the extracellular domain of the TLR4 protein have been widely studied. Environmental endotoxins are important triggers of asthma. These 2 variants have been reported to be associated with a blunted response to inhaled endotoxin on bronchial challenge testing and a reduced systemic inflammatory response to low-dose inhaled endotoxin \[[@b42-medscimonit-21-3591],[@b46-medscimonit-21-3591]\]. Non-carriers of these polymorphisms have been found to be more frequently affected by asthma \[[@b12-medscimonit-21-3591]\]. Several case-control studies have evaluated the association of TLR4 +896A/G and +1196C/T polymorphisms with asthma susceptibility. However, the results remain controversial. A previous meta-analysis has shown a marginal association of TLR4 +896A/G with asthma, and no association between TLR4 +1196C/T polymorphism and asthma \[[@b32-medscimonit-21-3591]\]. However, the previous meta-analysis did not cover all eligible studies related to asthma. Therefore, to obtain a more precise conclusion we conducted this meta-analysis including all eligible case-control studies.

On the basis of 7 case-control studies including 1443 asthma cases and 1693 controls, the present meta-analysis found that TLR4 +1196C/T polymorphism might be a protective factor against the development of asthma. This result is different from the previous meta-analysis. The discrepancy stemmed from the fact that Tizaoui and coworkers only included 4 studies with 541 asthma cases and 486 controls. Next, we conducted the stratified analysis by ethnicity. A significant protective association between TLR4 +1196C/T polymorphism and asthma was detected in Asians. However, we found no significant relationship between TLR4 +1196C/T polymorphism and asthma in whites. These results suggest that the effect of TLR4 +1196C/T polymorphism on asthma risk might be influenced by ethnicity. More studies should be performed based on different ethnic groups.

For TLR4 +896A/G polymorphism, no significant correlation was observed between TLR4 +896A/G polymorphism and asthma risk. The results remained non-significant after subgroup analysis by ethnicity. Our results are consistent with previous meta-analyses \[[@b32-medscimonit-21-3591],[@b47-medscimonit-21-3591],[@b48-medscimonit-21-3591]\]. Therefore, TLR4 +896A/G polymorphism seemed not to be associated with the risk of asthma development. However, a study conducted in Turkish children with asthma observed that both TLR4 +896A/G and +1196C/T polymorphisms were statistically more frequent in the mild asthma group \[[@b49-medscimonit-21-3591]\]. A strong association between TLR4 +896A/G and asthma course has been found in a Russian study, which reported that the minor G allele was associated with moderate/severe asthma \[[@b26-medscimonit-21-3591]\]. In addition, the G allele has been suggested to be significantly associated with moderate-severe asthma compared to mild asthma in an Egyptian population study \[[@b27-medscimonit-21-3591]\]. These findings indicate that TLR4 +896A/G polymorphism might be associated with the severity of asthma, but not susceptibility to asthma.

Several limitations in this study should be addressed. Firstly, the number of studies and subjects included in the present meta-analysis were relatively small. Secondly, only published studies with sufficient data were included, so the possibility of publication bias cannot be completely ruled out, even though funnel plot and Egger's test did not detect publication bias. Thirdly, the frequencies of GG genotype and TT genotype were low, which may undermine the findings. Moreover, the potential interactions between gene-gene and gene-environment during development of asthma were not conducted due to a lack of original data. Considering these limitations, the results of the meta-analysis should be interpreted with caution. Well-designed case-control studies with larger sample sizes and different population characteristics are needed to confirm these results.

Conclusions
===========

In summary, this meta-analysis suggests that the T allele of the TLR4 +1196C/T might act as a protective factor against the development of asthma, but there was no significant association between TLR4 +896A/G polymorphism and risk of asthma. Larger well-designed studies based on different ethnic groups should be performed to confirm our findings.
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###### 

Characteristics of the studies included in the meta-analysis.

  Study          Year   Country     Ethnicity   Age        Atopic status   Cases   Controls   Genotyping method
  -------------- ------ ----------- ----------- ---------- --------------- ------- ---------- ----------------------------------------
  **+896A/G**                                                                                 
  Yang           2004   UK          Caucasian   Adults     Mixed           185     179        ARMS-PCR
  Adjers         2005   Finland     Caucasian   Adults     Mixed           243     401        TaqMan
  Liu            2005   China       Asian       Mixed      Atopic          197     156        PCR-RFLP
  Larocca        2006   Venezuela   American    Mixed      Mixed           100     100        PCR-RFLP
  Smit           2007   Denmark     Caucasian   Adults     Mixed           100     87         TaqMan
  Carvalho       2008   UK          Caucasian   Adults     Atopic          14      80         Bi-PASA
  Lachheb        2008   Tunisia     Caucasian   Children   Mixed           210     224        PCR-RFLP
  Voronko        2011   Russia      Caucasian   Mixed      Atopic          283     227        MALDI-TOF-MS
  Zaborowski     2011   Poland      Caucasian   Adults     Mixed           106     159        PCR-RFLP
  Hussein        2012   Egypt       Caucasian   Children   Mixed           500     251        ARMS-PCR
  Sahin          2014   Turkey      Caucasian   Adults     Mixed           131     75         RT-PCR
  Sinha          2014   India       Asian       Mixed      Mixed           481     483        PCR-RFLP
  Bahrami        2015   Iran        Caucasian   Adults     Mixed           99      120        PCR-RFLP
  **+1196C/T**                                                                                
  Liu            2005   China       Asian       Mixed      Atopic          197     156        PCR-RFLP
  Larocca        2006   Venezuela   American    Mixed      Mixed           100     100        PCR-RFLP
  Smit           2007   Denmark     Caucasian   Adults     Mixed           100     87         PCR-SSP
  Lachheb        2008   Tunisia     Caucasian   Children   Mixed           210     224        PCR-RFLP
  Smit           2009   France      Caucasian   Adults     Mixed           224     568        Taqman and Illumina Golden Gate assays
  Sahin          2014   Turkey      Caucasian   Adults     Mixed           131     75         RT-PCR
  Sinha          2014   India       Asian       Mixed      Mixed           481     483        PCR-RFLP

ARMS-PCR -- amplification refractory mutation system-polymerase chain reaction; PCR-RFLP -- polymerase chain reaction-restriction fragment length polymorphism; Bi-PASA -- bidirectional polymerase chain reaction amplification of specific alleles; MALDI-TOF-MS -- matrix-assisted laser desorption/ionization time of flight mass spectrometry; RT-PCR -- real time polymerase chain reaction; PCR-SSP -- polymerase chain reaction with sequence-specific primers.

###### 

Distribution of TLR4 +896A/G and +1196C/T polymorphisms among patients and controls.

  Study          Cases    Controls   HWE(P)                              
  -------------- -------- ---------- -------- -------- -------- -------- ---------
  Yang           155      30         0        159      19       1        0.603
  Adjers         202      39         2        334      64       3        0.973
  Liu            161      29         7        128      23       5        0.006
  Larocca        91       9          0        92       8        0        0.677
  Smit           91       8          1        78       9        0        0.611
  Carvalho       12       2          0        70       10       0        0.551
  Lachheb        209      1          0        223      0        1        \< 0.01
  Voronko        245      31         7        200      27       0        0.341
  Zaborowski     94       12         0        142      17       0        0.476
  Hussein        434      64         2        223      27       1        0.851
  Sahin          122      9          0        71       4        0        0.812
  Sinha          390      87         4        381      95       7        0.699
  Bahrami        85       14         0        104      16       0        0.434
  **+1196C/T**   **CC**   **CT**     **TT**   **CC**   **CT**   **TT**   
  Liu            191      4          2        150      5        1        \< 0.01
  Larocca        95       4          1        94       6        0        0.757
  Smit           93       6          1        77       10       0        0.570
  Lachheb        209      0          1        221      2        1        \< 0.01
  Smit           198      26         0        492      76       0        0.087
  Sahin          120      11         0        71       4        0        0.812
  Sinha          408      68         5        384      92       7        0.581

HWE -- Hardy-Weinberg equilibrium.

###### 

Summary ORs and 95%CI of TLR4 +896A/G and +1196C/T polymorphisms and asthma risk.

  Subgroup           Genetic model    Genotype/Allele   Type of model   Heterogeneity   Test of association                             
  ------------------ ---------------- ----------------- --------------- --------------- --------------------- ------------ ------------ ------
  **+896A/G**                                                                                                                           
  Overall            Dominant model   GG+AG *vs.* AA    Fixed           0.0%            0.99                  1.05         0.89--1.24   0.56
  Codominant model   AG *vs.* AA      Fixed             0.0%            0.97            1.04                  0.88--1.23   0.64         
  Allele model       G *vs.* A        Fixed             0.0%            0.97            1.05                  0.90--1.23   0.51         
  Caucasians         Dominant model   GG+AG *vs.* AA    Fixed           0.0%            1.00                  1.14         0.92--1.41   0.22
  Codominant model   AG *vs.* AA      Fixed             0.0%            0.96            1.12                  0.90--1.39   0.32         
  Allele model       G *vs.* A        Fixed             0.0%            0.99            1.16                  0.95--1.42   0.15         
  Asians             Dominant model   GG+AG *vs.* AA    Fixed           0.0%            0.62                  0.91         0.69--1.19   0.48
  Codominant model   AG *vs.* AA      Fixed             0.0%            0.74            0.92                  0.69--1.22   0.56         
  Allele model       G *vs.* A        Fixed             0.0%            0.52            0.91                  0.71--1.16   0.43         
  **+1196C/T**                                                                                                                          
  Overall            Dominant model   TT+CT *vs.* CC    Fixed           0.0%            0.83                  0.76         0.59--0.96   0.03
  Codominant model   CT *vs.* CC      Fixed             0.0%            0.75            0.74                  0.58--0.95   0.02         
  Allele model       T *vs.* C        Fixed             0.0%            0.87            0.79                  0.63--0.99   0.04         
  Caucasians         Dominant model   TT+CT *vs.* CC    Fixed           0.0%            0.52                  0.84         0.57--1.24   0.39
  Codominant model   CT *vs.* CC      Fixed             0.0%            0.40            0.82                  0.55--1.22   0.33         
  Allele model       T *vs.* C        Fixed             0.0%            0.65            0.87                  0.60--1.26   0.46         
  Asians             Dominant model   TT+CT *vs.* CC    Fixed           0.0%            0.84                  0.70         0.51--0.96   0.03
  Codominant model   CT *vs.* CC      Fixed             0.0%            0.89            0.69                  0.50--0.96   0.03         
  Allele model       T *vs.* C        Fixed             0.0%            0.67            0.73                  0.54--0.98   0.04         
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